Oral vitamin C alone added to standard wound care,
does it really help with Complete healing and healing-time reduction in pressure ulcers?
research showsGrade D with 30 points. In an 88-person 12-week trial, complete-closure HR was 0.78 with a 90% interval of 0.44 to 1.39, and wound-area healing did not improve.
ads claimA biochemical role in collagen synthesis does not establish that extra high doses accelerate clinical ulcer healing.
Useful facts when choosing a product
- This verdict concerns single-ingredient oral vitamin C and does not automatically include foods, combinations, or intravenous infusion.
- Trials with different doses, durations, and populations were not treated as interchangeable.
- High oral doses can cause gastrointestinal effects; caution is warranted with stone risk, kidney disease, or iron overload.
Chamgap Semantic Classification Code
Permanent code issued
S.vitamin-c.oral.pressure-ulcer-healing.improve.activeSupplements and nutraceuticals > Vitamin C > Oral > Pressure-ulcer healing > Improvement claim > Active comparator
Permanent semantic code issued with the low-dose vitamin C active comparator used in the key trial. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | S · Supplement or nutraceutical |
|---|---|
| Canonical ingredient or intervention | Vitamin C |
| Source or part used | Purified nutrient. Feedstock, manufacturing process and country are unverified; plant part is not applicable. |
| Formulation or processing | Single-ingredient ascorbic acid supplement; unverified tablet/capsule, salt and excipient details are flagged by study. |
| Route | Oral |
| Dose | Main trial500 mg twice daily versus10 mg twice daily |
| Duration | Twelve-week main trial; separate four-week early trial |
| Population | Adults with pressure ulcers in nursing homes/hospital; deficiency and nutritional status require separate analysis |
| Effect or condition | Acceleration of pressure-ulcer healing |
| Primary endpoint | Complete closure/time to healing(H) separated from area reduction(S) |
| Comparator | Standard wound care plus low-dose vitamin C active control; early placebo comparison separate |
| Duplicate-detection key | vitamin-c|oral|pressure-ulcer-patients|pressure-ulcer-healing|low-dose-active-control |
What the research actually shows
Institutional patients received standardized care with high- or low-dose vitamin C; this was not a multinutrient-formula attribution study.
Why this is classified as D (30)
An independent closure trial is a strength, but the key trial was null and conflicts with a small early study. E0 with one I2 strength gives D with 30 points.
Counterpoint. Unresolved deficiency subgroups limit interpretation of both positive and negative findings.
Rejudgment record. Independent Codex cross-check — One page, one route, one population, one claim, one principal comparator
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R0 | Trials conflict in direction |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
The scoring table and the verdict agree (D).
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Ascorbic acid supplementation in the treatment of pressure-sores | Double-blind controlled study | 20 | Unverified | Pressure-sore area | Mean reduction84%vs42.7%,P<.005;originalCI and closurecounts unverified | Early area signal;deficiency strata unknown |
| Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers | Multicentre blinded RCT,ITT | 1 | Unverified | Wound closure and healingmeasures | ClosureHR.78,90%precision interval.44–1.39;areahealing.21vs.27cm²/week;not a95%CI | Main independent negative;active low-dose control |
Receipt — 2 References
Of 2 cited sources, 2 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-09-07.
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none
Cite this verdict
[Chamgap] Oral Vitamin C for Pressure-Ulcer Healing—No Benefit in an 88-Person 12-Week Trial — Evidence Grade D·30. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/oral-vitamin-c-pressure-ulcer-healing/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.